Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
Porta R., Sánchez-Torres J.M., Paz-Ares L., Massutí B., Reguart N., Mayo C., Lianes P., Queralt C., Guillem V., Salinas P., Catot S., Isla D., Pradas A., Gúrpide A., de Castro J., Polo E., Puig T., Tarón M., Colomer R., Rosell R.
Source: Eur Respir J 2011; 37: 624-631
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Porta R., Sánchez-Torres J.M., Paz-Ares L., Massutí B., Reguart N., Mayo C., Lianes P., Queralt C., Guillem V., Salinas P., Catot S., Isla D., Pradas A., Gúrpide A., de Castro J., Polo E., Puig T., Tarón M., Colomer R., Rosell R.. Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation. Eur Respir J 2011; 37: 624-631
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: